Clinical trial
Genome-wide Association Study (GWAS) and Epigenome-wide Association Study (EWAS) in Patients With Erdheim-Chester Disease
NCT06332183 is registered in ClinicalTrials.gov with Augusto Vaglio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genome-wide Association Study (GWAS) and Epigenome-wide Association Study (EWAS) in Patients With Erdheim-Chester Disease
- Lead sponsor
- Augusto Vaglio
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 17, 2019
- Completion date
- October 1, 2024
- Enrollment
- 300 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.